ES534815A0 - Un procedimiento para producir un preparado de gamma-interferon estable - Google Patents

Un procedimiento para producir un preparado de gamma-interferon estable

Info

Publication number
ES534815A0
ES534815A0 ES534815A ES534815A ES534815A0 ES 534815 A0 ES534815 A0 ES 534815A0 ES 534815 A ES534815 A ES 534815A ES 534815 A ES534815 A ES 534815A ES 534815 A0 ES534815 A0 ES 534815A0
Authority
ES
Spain
Prior art keywords
procedure
producing
interferon preparation
stable gamma
gamma
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
ES534815A
Other languages
English (en)
Other versions
ES8505545A1 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Mitsubishi Tanabe Pharma Corp
Original Assignee
Green Cross Corp Japan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP14348483A external-priority patent/JPS6034919A/ja
Priority claimed from JP58157560A external-priority patent/JPH0651641B2/ja
Application filed by Green Cross Corp Japan filed Critical Green Cross Corp Japan
Publication of ES534815A0 publication Critical patent/ES534815A0/es
Publication of ES8505545A1 publication Critical patent/ES8505545A1/es
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19—Cytokines; Lymphokines; Interferons
    • A61K38/21—Interferons [IFN]
    • A61K38/217—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/42—Proteins; Polypeptides; Degradation products thereof; Derivatives thereof, e.g. albumin, gelatin or zein

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Immunology (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
ES534815A 1983-08-04 1984-08-02 Un procedimiento para producir un preparado de gamma-interferon estable Expired ES8505545A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP14348483A JPS6034919A (ja) 1983-08-04 1983-08-04 ガンマ・インタ−フェロン組成物
JP58157560A JPH0651641B2 (ja) 1983-08-29 1983-08-29 ガンマ・インターフェロン組成物

Publications (2)

Publication Number Publication Date
ES534815A0 true ES534815A0 (es) 1985-06-01
ES8505545A1 ES8505545A1 (es) 1985-06-01

Family

ID=26475198

Family Applications (1)

Application Number Title Priority Date Filing Date
ES534815A Expired ES8505545A1 (es) 1983-08-04 1984-08-02 Un procedimiento para producir un preparado de gamma-interferon estable

Country Status (4)

Country Link
EP (1) EP0133767B1 (es)
CA (1) CA1223207A (es)
DE (1) DE3484374D1 (es)
ES (1) ES8505545A1 (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5643566A (en) * 1982-09-23 1997-07-01 Cetus Corporation Formulation processes for lipophilic proteins
US5702699A (en) * 1982-09-23 1997-12-30 Cetus Corporation Process for the recovery of lipophilic proteins
US4797388A (en) * 1984-05-21 1989-01-10 Cetus Corporation Pharmaceutical compositions with galactitol as carrier
FI861193A (fi) * 1985-03-25 1986-09-26 Schering Corp Stabilt gammainterferonpreparat.
GB8522336D0 (en) * 1985-09-09 1985-10-16 Biogen Nv Composition for treatment of allergies
US4933433A (en) * 1986-01-31 1990-06-12 E. I. Du Pont De Nemours And Company Recombinant interleukin-2 composition and process for making it
US5183746A (en) * 1986-10-27 1993-02-02 Schering Aktiengesellschaft Formulation processes for pharmaceutical compositions of recombinant β-
US5037644A (en) * 1986-10-27 1991-08-06 Cetus Corporation Pharmaceutical compositions of recombinant interleukin-2 and formulation processes
US4895716A (en) * 1987-06-09 1990-01-23 Biogen, Inc. Stabilized formulations of gamma interferons
US5151265A (en) * 1987-11-03 1992-09-29 Genentech, Inc. Gamma interferon formulation
US5004605A (en) * 1987-12-10 1991-04-02 Cetus Corporation Low pH pharmaceutical compositions of recombinant β-interferon
IT1216056B (it) * 1988-03-11 1990-02-22 Sclavo Spa Composizioni farmaceutiche contenenti timosina alfa 1.
US5078997A (en) * 1988-07-13 1992-01-07 Cetus Corporation Pharmaceutical composition for interleukin-2 containing physiologically compatible stabilizers
US5997856A (en) * 1988-10-05 1999-12-07 Chiron Corporation Method and compositions for solubilization and stabilization of polypeptides, especially proteins
CA2024046A1 (en) * 1989-09-28 1991-03-29 Alberto Ferro Stabilized leukocyte-interferons
LT3987B (en) 1992-02-17 1996-06-25 Fermentas Biotech Inst Stabilized interferon compositions
AP1168A (en) * 1996-05-09 2003-06-30 Feronpatent Ltd Stabilization of interferons in aqueous solution for manufacture of sublingually administered tablets.
AU730020B2 (en) * 1997-05-09 2001-02-22 Feronpatent Limited Stabilisation of interferons in aqueous solution for manufacture of sublingually administered tablets
WO1999006429A1 (fr) * 1997-08-01 1999-02-11 Toray Industries, Inc. Stabilisation de proteines utiles et compositions a base de proteines utiles
CA2428144C (en) 2000-11-07 2012-01-10 Chiron Corporation Compositions of interferon-beta stabilized with highly purified mannitol
US6887462B2 (en) 2001-04-09 2005-05-03 Chiron Corporation HSA-free formulations of interferon-beta
EG24184A (en) 2001-06-15 2008-10-08 Otsuka Pharma Co Ltd Dry powder inhalation system for transpulmonary

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
ZA83768B (en) * 1982-03-01 1983-10-26 Hoffmann La Roche Homogeneous human immune interferon and process therefor
WO1984002129A1 (en) * 1982-11-22 1984-06-07 Takeda Chemical Industries Ltd Human immune interferon protein and process for its preparation

Also Published As

Publication number Publication date
CA1223207A (en) 1987-06-23
EP0133767A3 (en) 1986-12-17
ES8505545A1 (es) 1985-06-01
EP0133767B1 (en) 1991-04-03
DE3484374D1 (de) 1991-05-08
EP0133767A2 (en) 1985-03-06

Similar Documents

Publication Publication Date Title
ES534815A0 (es) Un procedimiento para producir un preparado de gamma-interferon estable
ES548135A0 (es) Un procedimiento para preparar dioxafosforinanos
ES543192A0 (es) Un procedimiento para preparar aril-hidroxamatos
ES537440A0 (es) Un procedimiento para preparar 1-amino-4-nitro-acridinonas sustituidas
ES530759A0 (es) Un procedimiento para preparar conjugados de galactosil-insulina
ES534694A0 (es) Un procedimiento para preparar cefuroxima sodica
ES531483A0 (es) Un procedimiento para la preparacion de carboxamidas
ES536865A0 (es) Un procedimiento para producir un complejo de platino-diamino
ES533873A0 (es) Un procedimiento para preparar profarmacos de alopurinol
ES545270A0 (es) Un procedimiento para la obtencion de piridoindoles
ES536152A0 (es) Un procedimiento para producir l-arginina
ES543929A0 (es) Un procedimiento para preparar un p-isononanoiloxibenceno- sulfonato
ES549860A0 (es) Un procedimiento para preparar aminoacil-ladanos
ES546157A0 (es) Un procedimiento para preparar quinolonas
ES531550A0 (es) Procedimiento para preparar un fenilaminobencoalcanol
ES542149A0 (es) Un procedimiento para preparar hidroxi-4-2h-1-benzotiopiran-2-onas
ES536050A0 (es) Un procedimiento para preparar fenil-carbamatos sustituidos
ES544864A0 (es) Un procedimiento para preparar 4-acetoxi-3-hidroxietilazeti-zin-2-ona
ES534170A0 (es) Un procedimiento para preparar 1-piridil-alquil-4-aril-piperazinas
ES538072A0 (es) Un procedimiento para preparar un difenil-eter
ES544251A0 (es) Un procedimiento para la preparacion de benzoquinolicinas
ES536293A0 (es) Un procedimiento para producir derivados de acilindol
ES535847A0 (es) Un procedimiento para producir un uroquinasa-zimogeno
ES530037A0 (es) Procedimiento para preparar imidazolamidas
ES534701A0 (es) Un procedimiento para producir l-isoleucina